11:15 AM EDT, 04/08/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.91% to 1,261.50 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS ( EDAP ) and biopharmaceutical company Cellectis ( CLLS ) , which advanced 20% and 9.5% respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and Spanish lender Banco Santander (SAN), which climbed 7.8% and 5% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and oil and gas company Eni (E), which lost 6.3% and 1.3% respectively. They were followed by telecommunications operator Telefonica (TEF) and oil and gas company TotalEnergies (TTE), which were down 0.7% and 0.6% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and cruise line operator Carnival (CUK), which rose 9.5% and 7.1% respectively. They were followed by biopharmaceutical companies Verona Pharma ( VRNA ) and Mereo BioPharma Group ( MREO ) , which advanced 3.9% and 3.8%respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and lender HSBC ( HSBC ) , which dropped 8.6% and 1.9% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and biotechnology firm Trinity Biotech ( TRIB ) , which fell 1.8% and 1.7% respectively.